Vitamin D Market Report 2025

This Vitamin D report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The vitamin d market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to increased awareness of vitamin d deficiency, growing aging population, rise in osteoporosis cases, expansion of functional food market, government initiatives for vitamin d fortification.

The vitamin d market size is expected to see rapid growth in the next few years. It will grow to $2.7 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising demand for dietary supplements, emphasis on preventive healthcare, growing consumer interest in health and wellness, research advances in vitamin d benefits, increasing incidence of chronic diseases. Major trends in the forecast period include fortification of various food products with vitamin d, expansion of vegan vitamin d sources, personalized nutrition and vitamin d testing, adoption of vitamin d in beauty and skin care products, online retailing of vitamin d supplements.

The increasing incidence of osteoporosis among women is expected to drive the growth of the vitamin D market. Osteoporosis is a bone disease characterized by a decrease in bone mineral density and mass, as well as changes in bone quality or structure. This condition is often caused by insufficient levels of calcium and vitamin D in the body, raising the risk of fractures. Other contributing factors include a family history of osteoporosis, a parental history of hip fractures, a lower body mass index (BMI), and the female gender, which is associated with smaller, thinner bones compared to men. The rising prevalence of osteoporosis in women is likely to result in greater demand for vitamin D, an essential nutrient that aids in the absorption of calcium and phosphorus from food and helps build stronger bones in women after menopause. It also plays a role in treating conditions that lead to weak bones. For example, in September 2023, data from the Canadian Longitudinal Study on Aging, reported by the National Center for Biotechnology Information, indicated that 12.7% of females in community-dwelling older adults were diagnosed with osteoporosis by a physician, while 5.9% had DXA-confirmed osteoporosis. Additionally, a cross-sectional study by Buttros and colleagues found a 24.6% prevalence of osteoporosis in postmenopausal women aged 40 to 75, based on bone mineral density (BMD) measurements. Therefore, the rising incidence of osteoporosis in women is set to drive the growth of the vitamin D market.

The growth of the vitamin D market is further driven by the increasing prevalence of vitamin D deficiency. Vitamin D deficiency occurs when the body's vitamin D levels fall below normal, resulting in bone mineral loss, bone pain, muscle weakness, and bone softening. Notably, vitamin D supplements are utilized for treating severe deficiencies. According to data from HealthMatch in November 2022, 42% of adults in the US experienced vitamin D deficiencies, while 50% of children aged one to five and 70% of children aged six to eleven were affected by vitamin D deficiency. This growing prevalence of vitamin D deficiency contributes significantly to the expansion of the vitamin D market.

The emergence of faster-acting vitamin D supplements is a significant trend gaining traction in the vitamin D market. These supplements are designed to help achieve optimal vitamin D levels in the body more quickly than traditional vitamin D formulations. They are innovative and effective solutions used to address severe vitamin D deficiency more rapidly, facilitating quicker recovery for patients. Leading companies are focusing on providing these faster-acting vitamin D supplements to enhance their competitive position in the market. For example, in February 2024, Cadila Pharmaceuticals Ltd., an Indian pharmaceutical company, introduced an aqueous vitamin D injection. This innovative aqueous formulation of cholecalciferol offers a rapid solution for vitamin D deficiency, demonstrating improved pharmacokinetics and pharmacodynamics compared to conventional oil-based preparations, while also ensuring painless administration. This advancement addresses the urgent demand for quicker treatment results, thereby enhancing patient adherence to their treatment regimens.

Leading companies in the vitamin D market are focusing on product innovation, exemplified by the introduction of calcium and D3 gummies. These gummies combine essential nutrients, vitamin D3 and calcium, in a palatable and convenient form, particularly beneficial for individuals who struggle with traditional medication forms. Nutrazee, an India-based vegan dietary supplement brand, launched vegan vitamin D3 and calcium gummies in January 2022. These gummies are gluten-free, non-GMO, and free of artificial colors, catering to diverse dietary preferences and needs. Each serving of two gummies provides 200mg of calcium and 400 IU of vitamin D3, while a serving of three gummies contains 300mg of calcium and 600 international units of vitamin D3.

In July 2022, Nestlé Health Science S. A. acquired Puravida, a Belgium-based nutrition and lifestyle company, for an undisclosed amount. This acquisition aims to leverage Puravida's expertise in nutrition research and development, expanding the portfolio's breadth and depth across consumer and healthcare professional channels. The collaboration is expected to drive innovation, increase brand visibility, and create new growth opportunities.

Major companies operating in the vitamin d market include BASF SE, Koninklijke DSM NV, Fermenta Biotech Ltd., Xiamen Kingdomway Vitamin Co. Ltd., Zhejiang Medicine Co. Ltd., Abbott Laboratories, Bayer AG, Bluebonnet Nutrition, Carlson Labs, Country Life LLC, Doctor's Best Inc., Douglas Laboratories, Garden of Life LLC, GlaxoSmithKline plc, Jarrow Formulas, Kirkland Signature, Life Extension, Merck & Co. Inc., Metagenics LLC, Pharmavite LLC, Nature's Bounty Co. Ltd., Nestlé Health Science SA, Pfizer Inc., Protocol for Life Balance Inc., Pure Encapsulations Inc., Sanofi S. A., Source Naturals Inc., Sundown Naturals Inc., Swanson Health Products Inc., Twinlab Consolidated Corporation, Vital Nutrients Company Inc.

North America was the largest region in the vitmain D market in 2024. The regions covered in the vitamin d market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vitamin d market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Vitamin D is a crucial nutrient required by the body in small amounts to maintain overall health. It plays a vital role in the absorption of calcium and phosphorus, essential for the development and maintenance of healthy bones and teeth. Vitamin D is soluble in fats and oils and is found in various food sources such as dairy products, fatty fish, and egg yolks.

There are two main types of vitamin D, vitamin D3 (cholecalciferol) and vitamin D2. Vitamin D3 is primarily derived from animal-based sources like oil, egg yolk, and butter, as well as dietary supplements. It facilitates the absorption of calcium in the body and is often used to treat conditions such as osteomalacia or rickets. Vitamin D3 is available in different strengths measured in International Units (IU), including 500,000 IU, 100,000 IU, and 40 MIU, and can be in oil or powder form. It is suitable for adults, pregnant women, and children to support their nutritional needs.

The vitamin D market research report is one of a series of new reports that provides vitamin D market statistics, including vitamin D industry global market size, regional shares, competitors with a vitamin D market share, detailed vitamin D market segments, market trends and opportunities, and any further data you may need to thrive in the vitamin D industry. This vitamin D market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vitamin D market consists of sales of ergocalciferol, cholecalciferol, and pre-vitamin D. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.